BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21384080)

  • 1. Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques.
    Hurtado B; Muñoz X; Recarte-Pelz P; García N; Luque A; Krupinski J; Sala N; García de Frutos P
    Thromb Haemost; 2011 May; 105(5):873-82. PubMed ID: 21384080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
    Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
    Elife; 2014 Sep; 3():. PubMed ID: 25265470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis.
    Hurtado B; Abasolo N; Muñoz X; García N; Benavente Y; Rubio F; García de Frutos P; Krupinski J; Sala N
    Thromb Haemost; 2010 Sep; 104(3):592-8. PubMed ID: 20664904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenal mucosa of untreated celiac disease patients has altered expression of the GAS6 and PROS1 and the negative regulator tyrosine kinase TAM receptors subfamily.
    Perez F; Iribarren ML; Olexen CM; Ruera CN; Errasti AE; Guzman L; Garbi L; Carrera Silva EA; Chirdo FG
    Clin Immunol; 2024 Jun; 263():110202. PubMed ID: 38575045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.
    Shafit-Zagardo B; Gruber RC; DuBois JC
    Pharmacol Ther; 2018 Aug; 188():97-117. PubMed ID: 29514053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.
    Al Kafri N; Hafizi S
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
    Kasikara C; Kumar S; Kimani S; Tsou WI; Geng K; Davra V; Sriram G; Devoe C; Nguyen KN; Antes A; Krantz A; Rymarczyk G; Wilczynski A; Empig C; Freimark B; Gray M; Schlunegger K; Hutchins J; Kotenko SV; Birge RB
    Mol Cancer Res; 2017 Jun; 15(6):753-764. PubMed ID: 28184013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
    Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
    J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Gas6 and Axl signaling results in extensive axonal damage, motor deficits, prolonged neuroinflammation, and less remyelination following cuprizone exposure.
    Ray AK; DuBois JC; Gruber RC; Guzik HM; Gulinello ME; Perumal G; Raine C; Kozakiewicz L; Williamson J; Shafit-Zagardo B
    Glia; 2017 Dec; 65(12):2051-2069. PubMed ID: 28925029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gas6/TAM System and Multiple Sclerosis.
    Bellan M; Pirisi M; Sainaghi PP
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer.
    Schmitz R; Valls AF; Yerbes R; von Richter S; Kahlert C; Loges S; Weitz J; Schneider M; Ruiz de Almodovar C; Ulrich A; Schmidt T
    Oncotarget; 2016 Aug; 7(35):56355-56370. PubMed ID: 27486820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily.
    Hafizi S; Dahlbäck B
    FEBS J; 2006 Dec; 273(23):5231-44. PubMed ID: 17064312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.
    Waterborg CEJ; Koenders MI; van Lent PLEM; van der Kraan PM; van de Loo FAJ
    PLoS One; 2018; 13(10):e0205902. PubMed ID: 30335822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
    Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
    Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-phosphorylation, signaling and proliferative functions of the Tyro3 and Axl receptors in Rat2 cells.
    Brown JE; Krodel M; Pazos M; Lai C; Prieto AL
    PLoS One; 2012; 7(5):e36800. PubMed ID: 22606290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte and plasma expression of TAM ligand and receptor in renal failure: Links to unregulated immunity and chronic inflammation.
    Lee IJ; Hilliard BA; Ulas M; Yu D; Vangala C; Rao S; Lee J; Gadegbeku CA; Cohen PL
    Clin Immunol; 2015 Jun; 158(2):231-41. PubMed ID: 25814173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids?
    Garbin U; Baggio E; Stranieri C; Pasini A; Manfro S; Mozzini C; Vallerio P; Lipari G; Merigo F; Guidi G; Cominacini L; Fratta Pasini A
    Cardiovasc Res; 2013 Jan; 97(1):125-33. PubMed ID: 22997156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
    Tutusaus A; Morales A; García de Frutos P; Marí M
    Semin Liver Dis; 2024 Feb; 44(1):99-114. PubMed ID: 38395061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.
    Kimani SG; Kumar S; Bansal N; Singh K; Kholodovych V; Comollo T; Peng Y; Kotenko SV; Sarafianos SG; Bertino JR; Welsh WJ; Birge RB
    Sci Rep; 2017 Mar; 7():43908. PubMed ID: 28272423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.